P131 International Benchmarking on Psoriasis Pharmacoepidemiology: Epidemiology, Etiologies, Symptoms, Treatment and Prevention
Abstract Psoriasis which can involve the skin, nails and joints, is classified by the World Health Organisation as chronic, painful, disfiguring and disabling non communicable disease (NCD) for which there is no specific and definitive cure.1 Why Psoriasis is very difficult to treat? It is like this, because, it looks like many skin diseases at the same time,2 with no specific clinical aspects and many factory interacting together: Environmental, Psychological, Immunological, Genetic and Physiological. As a result, the therapeutic solution will be difficult in most clinical cases and will take time for a definitive recovery. This lead us to prepare an international Benchmarking on Psoriasis Pharmacoepidemiology: Epidemiology, Etiologies, Symptoms, Treatment and Prevention. Despite Of Corticosteroids, which are the best medicine for many diseases all over the world, there are other medicines to use Therefore, scientists have been fighting for so many years, to find new medicines and therapeutic protocols especially natural ones, using herbs and nutritional methods to treat Psoriasis. This study will give us an holistic overview from the theoretical recovery guarentees of varied treatments in different countries worldwide (using Argan oil in Morocco, using Vitamin d in France,...) to the Pratical recovery constraints.
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1093/bjd/ljae360.161
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00